We are delighted to host Rinn Advanced Therapies at Trinity College Dublin, and are inspired by the transformative potential of this National Research Centre. Together with our collaborators, we are advancing impactful research that has the power to change lives, and brings us closer to a future where patients in Ireland can benefit from personalised, cutting-edge cellular immunotherapies developed and delivered by the Centre.
I am especially proud that our colleagues, Professor Sakis Mantalaris, Professor of Pharmaceutical Biology in the School of Pharmacy and Pharmaceutical Sciences, is providing visionary leadership as Director of Rinn Advanced Therapies, along with Professor Nicki Panoskaltsis, Professor of Personalised Therapeutics, who is co-leading the research and translation.
Driven by ambition and purpose, it is our mission to firmly establish the School as a global leader in Advanced Therapies, shaping innovation, accelerating discovery, and improving patient outcomes both nationally and internationally. Our goals are to develop ground-breaking advanced therapies and to train pharmacists and industry professionals in manufacturing, regulation, and clinical application of these new medicines towards improved patient outcomes.
Dr Astrid Sasse, Head of the School of Pharmacy and Pharmaceutical Sciences
More information about the Research Ireland-funded Rinn centres can be found here.
